Feodor Felix Konrad Lynen
|
Error creating thumbnail: /home/webapps/wikidoc/mediawiki-1.19.2/bin/ulimit4.sh: line 4: r: command not found |
Please help improve this article by expanding it. Further information might be found on the talk page or at requests for expansion. This article has been tagged since February 2007. |
| {{{name}}} | |
| [[Image:|300px| ]] | |
| Data 1: | |
|---|---|
| Data 2: | April 6, 1911 Munich, Germany |
| Data 3 (data hidden if data3 empty or not defined): | August 6 1979 (aged 68) Munich, Germany |
Feodor Felix Konrad Lynen (6 April 1911 – 6 August 1979) was a German biochemist.
Biography
Feodor Lynen was born in Munich, Germany on April 6, 1911. He started his studies at the chemistry department of Munich University in 1930 and graduated in March 1937 under Heinrich Wieland with the work: "On the Toxic Substances in Amanita". After several years of lecturing there, Lynen became professor at the Munich University in 1947. From 1954 onwards he was director of the Max-Planck Institute for Cellular Chemistry in Munich, which was merged into the newly founded Max-Planck Institute of Biochemistry in 1972.
In 1964 he won the Nobel Prize in Medicine and Physiology together with Konrad Bloch for their discoveries concerning the mechanism and regulation of cholesterol and fatty acid metabolism. He gave his Nobel Lecture on 11 December 1964 titled The Pathway from Activated Acetic Acid to the Terpenes and Fatty Acids.
Fellowship
The Alexander von Humboldt Foundation has a fellowship named in his honor.
External links
Template:Chemist-stubca:Feodor Lynen cs:Feodor Lynen de:Feodor Lynensk:Feodor Felix Konrad Lynen sv:Feodor Lynen
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies